4Wilson PWF, Agostino RBD, LeW D, et al. Prediction of coronary heart disease using risk factor categories (Framingham). Circulation, 1998,97 : 1837 - 1847.
5Vasan RS, Kannel WB. Strategies for cardiovascular risk assessment and prevention over the life course: progress amid imperfections[J]. Circulation,2009, (120)5:360 - 363.
6Truer J, Cornfield J, Kannel WB. A multivariate analysis of the risk of coronary heart disease in Framingham. J Chronic Dis, 1967,20:511 - 524.
7Scheltens T, Verschuren WM, Boshuizen HC, et al. Estimation of cardiovascular risk: a comparison between the Framingham and the SCORE model in people under 60 years of age[J]. Eur J Cardiovasc Prev Rehabil, 2008, 15(5) :562 - 566.
8Lloyd-Jones DM, Evans JC, Larson MG, et al. Cross-classification of JNC Ⅵ blood pressure stages and risk groups in the Framingham Heart Study [J]. Arch Intern Med, 1999, 159(18):2206-2212.
9Ingelsson E, Gona P, Larson MG, et al. Altered blood pressure progression in the community and its relation to clinical events[J]. Arch Intern Med, 2008,168(13) : 1450 - 1457.
10Manna AK, Lloyd-Jones DM. Systematic examination of the updated Framingham heart study general cardiovascular risk profile[J]. Circulation, 2009, ( 120)5 : 384 - 390.
二级参考文献10
1Truett J, Cornfield J, Kannel W. A multivariate analysis of the risk of coronary heart disease in Framingham. J Chronic Dis,1967,20:511-524.
2Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus.Diabetes Care,2003,26(Suppl 1):S5-S20.
3Wilson PW, D′Agostino RB, Levy D,et al. Prediction of coronary heart disease using risk factor categories.Circulation,1998, 97:1837-1847.
4Grundy SM, Balady GJ, Criqui MH,et al.Primary prevention of coronary heart disease: guidance from Framingham: a statement for healthcare professionals from the AHA Task Force on Risk Reduction. American Heart Association.Circulation,1998,97: 1876-1887.
3Wilson WF, D'Agostino RB, Levy D, et al. Prediction of coronary heart disease using risk factor categories (Framingham) [J]. Circulation, 1998,97( 18): 1837-1847.
4Mandeep S. Framingham equations overestimate risk of coronary heart disease mortality in British males[ J]. EBH, 2004,8( 3 ): 131-132.
5Collins GS, Ahman DG. An independent external validation and evaluation of QR1SK cardiovascular risk prediction: a prospective open cohort study[J]. BMJ,2009, 339(7 ): b2584-b2593.
6de la Iglesia B, Potter JF, Poulter NR, et al. Performance of the ASSIGN cardiovascular disease risk score on a UK cohort of patients from general practice [ J]. Heart, 2011,97 ( 6 ):491-499.
7Conroy RM, Pyirala K, Fitzgerald AP, et al. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project[J]. Eur Heart J,2003, 24( 11 ): 987-1003.
8Assmann G, Schuhe H, Cullen P. New and classical risk factors-the Mtinster heart study (PROCAM) [J]. Eur J Med Res, 1997, 2(6): 237-242.
10Hippisley-Cox J, Coupland C, Vinogradova Y, et al. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2 [ J ]. BMJ, 2008,336 ( 7659 ): 1475 -1 482.
